Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement

被引:9
|
作者
Lebel, Ehud [1 ]
Elstein, Deborah [2 ]
Peleg, Ariel [2 ]
Remus, Constantine [3 ]
Zimran, Ari [2 ]
Amir, Gail [4 ]
机构
[1] Shaare Zedek Med Ctr, Dept Orthoped Surg, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Dept Pathol, IL-91031 Jerusalem, Israel
[4] Hadassah Med Ctr, Dept Pathol, Ein Kerem, Israel
关键词
Gaucher disease; Gaucher cells; Bone histology; Enzyme replacement therapy; Osteonecrosis; OSTEONECROSIS;
D O I
10.1309/AJCPFVSAEGO67NGT
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To assess correlations of patient demographics, including enzyme replacement therapy (ERT) with bone histology, to facilitate decisions of whether and when to perform hip replacement surgery in patients with Gaucher disease. Methods: We examined the histology of surgically removed femoral heads and categorized findings by the presence or extent of osteonecrosis, Gaucher cell (GC) infiltration, and bone regeneration qualifiers using a tripartite histology-based scoring system. Results: Twenty-two patients with 26 bone specimens were evaluated. Seventeen patients (77%) were splenectomized, 16 (73%) received ERT, and 12 (55%) had the putatively milder genotype (N370S/N370S), with the rest putatively at increased risk for skeletal disease (N370S/other). The 3 histology subscores were applicable to all specimens. Osteonecrotic bone was seen in 19 of 26 (73%); osteoarthritis was seen in all cartilage specimens. Gaucher cell infiltration was not correlated with demographics or disease severity. A trend was noted between reduced GC infiltration and ERT (rho = 0.407), but regeneration qualifiers were not correlated with ERT or other features. Conclusions: Histologic findings of GC infiltration and bone regeneration qualifiers did not correlate with demographics or with exposure to ERT. Most specimens unexpectedly showed good regenerative responses to osteonecrosis despite heavy GC infiltration.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [41] Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
    Smid, Bouwien E.
    Ferraz, Maria J.
    Verhoek, Marri
    Mirzaian, Mina
    Wisse, Patrick
    Overkleeft, Herman S.
    Hollak, Carla E.
    Aerts, Johannes M.
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [42] Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
    Bouwien E. Smid
    Maria J. Ferraz
    Marri Verhoek
    Mina Mirzaian
    Patrick Wisse
    Herman S. Overkleeft
    Carla E. Hollak
    Johannes M. Aerts
    Orphanet Journal of Rare Diseases, 11
  • [43] ATTEMPT AT ENZYME REPLACEMENT IN GAUCHER DISEASE BY RENAL-TRANSPLANTATION
    GROTH, CG
    COLLSTE, H
    DREBORG, S
    HAKANSSON, G
    LUNDGREN, G
    SVENNERHOLM, L
    ACTA PAEDIATRICA SCANDINAVICA, 1979, 68 (04): : 475 - 479
  • [44] Enzyme replacement therapy in a patient with type III Gaucher disease
    Carbajal-Rodriguez, Luis
    Gomez-Gonzalez, Ma. Fernanda
    Rodriguez-Herrera, Raymundo
    Zarco-Roman, Jorge
    Mora-Tiscareno, Ma. Antonieta
    ACTA PEDIATRICA DE MEXICO, 2012, 33 (01): : 9 - 19
  • [45] Gaucher disease with nephrotic syndrome: Response to enzyme replacement therapy
    Santoro, D
    Rosenbloom, BE
    Cohen, AH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01)
  • [46] Enzyme replacement: A new therapeutic approach in Gaucher's disease
    Beck, M
    Mengel, E
    Barone, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (03) : 81 - 85
  • [47] ENZYME REPLACEMENT THERAPY FOR GAUCHER DISEASE - SKELETAL RESPONSES TO MACROPHAGE-TARGETED GLUCOCEREBROSIDASE
    ROSENTHAL, DI
    DOPPELT, SH
    MANKIN, HJ
    DAMBROSIA, JM
    XAVIER, RJ
    MCKUSICK, KA
    ROSEN, BR
    BAKER, J
    NIKLASON, LT
    HILL, SC
    MILLER, SPF
    BRADY, RO
    BARTON, NW
    PEDIATRICS, 1995, 96 (04) : 629 - 637
  • [48] Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1?
    Matta, Marina Cadena
    Vairo, Filippo
    Torres, Leuridan Cavalcante
    Schwartz, Ida
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 200 - 202
  • [49] Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher disease
    Harel, Reut
    Gavish, Israel
    Aviv, Ariel
    Maravi, Nofar Greenman
    Trougouboff, Philippe
    Zimran, Ari
    Revel-Vilk, Shoshana
    INTERNAL MEDICINE JOURNAL, 2022, 52 (05) : 872 - 875
  • [50] The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States
    Farahbakhshian, Sepehr
    Inocencio, Timothy J.
    Poorman, Gregory
    Wright, Ekaterina
    Pathak, Ravi Ramesh
    Bullano, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 755 - 761